tiprankstipranks
Trending News
More News >
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
Hong Kong Market

Jacobio Pharmaceuticals Group Co., Ltd. (1167) Financial Statements

Compare
4 Followers

Jacobio Pharmaceuticals Group Co., Ltd. Financial Overview

Jacobio Pharmaceuticals Group Co., Ltd.'s market cap is currently HK$3.82B. The company's EPS TTM is HK$-0.217; its P/E ratio is ―; Jacobio Pharmaceuticals Group Co., Ltd. is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 155.71M¥ 63.52M¥ 95.75M¥ 152.81M¥ 486.29M
Gross Profit¥ 155.71M¥ 3.20M¥ 12.63M¥ 12.83M¥ 442.17M
Operating Income¥ -188.17M¥ -397.88M¥ -474.73M¥ -302.32M¥ 179.11M
EBITDA¥ -192.36M¥ -325.73M¥ -355.80M¥ -289.83M¥ -1.50B
Net Income¥ -155.71M¥ -359.12M¥ -374.88M¥ -292.29M¥ -3.21B
Balance Sheet
Cash & Short-Term Investments¥ 1.17B¥ 1.15B¥ 1.28B¥ 1.53B¥ 1.63B
Total Assets¥ 1.36B¥ 1.46B¥ 1.57B¥ 1.72B¥ 1.87B
Total Debt¥ 152.08M¥ 209.91M¥ 147.79M¥ 6.81M¥ 10.65M
Net Debt¥ -1.02B¥ -933.21M¥ -1.14B¥ -1.52B¥ -1.62B
Total Liabilities¥ 435.99M¥ 387.11M¥ 292.12M¥ 84.75M¥ 81.15M
Stockholders' Equity¥ 923.18M¥ 1.07B¥ 1.28B¥ 1.64B¥ 1.79B
Cash Flow
Free Cash Flow¥ -86.21M¥ -402.86M¥ -308.92M¥ -158.63M¥ 67.87M
Operating Cash Flow¥ -74.12M¥ -364.20M¥ -292.42M¥ -147.49M¥ 78.83M
Investing Cash Flow¥ 0.00¥ -48.00M¥ -686.32M¥ 161.67M¥ -215.56M
Financing Cash Flow¥ 21.28M¥ 246.28M¥ -9.85M¥ 109.06M¥ 1.28B
Currency in CNY

Jacobio Pharmaceuticals Group Co., Ltd. Earnings and Revenue History

Jacobio Pharmaceuticals Group Co., Ltd. Debt to Assets

Jacobio Pharmaceuticals Group Co., Ltd. Cash Flow

Jacobio Pharmaceuticals Group Co., Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis